Read + Share
Nahi H, Afram G, Brauner H, Talme T, et al. Pyoderma gangrenosum with plasma cell dyscrasia should be subject for
anti-myeloma treatment. Int J Dermatol 2021;60:e271-e273.
PMID: 33751551
|
 |
|
Nahi H, Afram G, Brauner H, Talme T, et al. Pyoderma gangrenosum with plasma cell dyscrasia should be subject for
anti-myeloma treatment. Int J Dermatol 2021;60:e271-e273.
PMID: 33751551
|
|
|
|